Clinical Trial News, Clinical Trials
Monday, June 9th, 2014
Ishib: 4/17/14 Objective: To evaluate community screening using HbA1c levels in high risk African Americans and Latinos in those not known to have diabetes. Design: HbA1c levels were measured in 1542 African Americans and Latinos aged $40 years with one or more of the following risk factors: family history in first degree relatives, waist circumference $40 […]
Clinical Trial News, Clinical Trials
Monday, June 9th, 2014
Diabetes Care May 8, 2014 OBJECTIVE Insulin degludec/insulin aspart (IDegAsp) is the first combination of a basal insulin with an ultralong duration of action, and a rapid-acting insulin in a single injection. This trial compared IDegAsp with biphasic insulin aspart 30 (BIAsp 30) in adults with type 2 diabetes inadequately controlled with once- or twice-daily (OD or […]
Clinical Trial News, Clinical Trials
Monday, June 9th, 2014
Diabetes Care April 23, 2014 OBJECTIVE To test whether a weight loss program promotes greater weight loss, glycemic control, and improved cardiovascular disease risk factors compared with control conditions and whether there is a differential response to higher versus lower carbohydrate intake. RESEARCH DESIGN AND METHODS This randomized controlled trial at two university medical centers enrolled 227 overweight […]
Clinical Trials, Clinical Trials
Monday, June 9th, 2014
Diabetes Care: April 17, 2014 OBJECTIVE To compare the efficacy and safety of two doses of once-weekly dulaglutide, a glucagon-like peptide 1 receptor agonist, to sitagliptin in uncontrolled, metformin-treated patients with type 2 diabetes. The primary objective was to compare (for noninferiority and then superiority) dulaglutide 1.5 mg versus sitagliptin in change from baseline in glycosylated hemoglobin […]
